barinthuslogo.jpg
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
25 nov. 2024 16h01 HE | Barinthus Biotherapeutics
OXFORD, United Kingdom and GERMANTOWN, Md., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), today announced the promotion of Geoffrey Lynn, M.D.,...
avacta.png
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
15 oct. 2024 07h00 HE | Avacta Group
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024 –...
avacta.png
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
15 oct. 2024 02h00 HE | Avacta Group
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024...
logo_ProQR-150x150.png
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
19 janv. 2024 07h00 HE | ProQR Therapeutics N.V.
Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human primates (NHPs) and miceFunctional effect demonstrated in mice in vivo via...
ACIU_CSO Madiha Derouazi
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
01 déc. 2023 07h00 HE | AC Immune SA
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO Outstanding scientist and entrepreneur Dr. Madiha Derouazi appointed as new CSORetiring CSO Dr....
Logo.jpg
GT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
24 févr. 2023 09h00 HE | GT Biopharma, Inc.
BRISBANE, CALIFORNIA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...
zailab.png
Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
08 nov. 2022 07h30 HE | Zai Lab Limited
SHANGHAI and CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today...
Michael Brubaker_High Res
Xequel Bio Expands Leadership Team with Appointments of Dr. Michael J. Brubaker as Chief Scientific Officer and Tony C. Tipton as Chief Operating Officer
26 juil. 2022 09h00 HE | Xequel Bio, Inc.
CHARLESTON, S.C. and FORT WORTH, Texas, July 26, 2022 (GLOBE NEWSWIRE) -- Xequel Bio, Inc., a clinical stage biopharmaceutical company developing dermatologic and ophthalmic therapeutics utilizing...
Element Logo for GNW.jpg
Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer
30 juin 2022 03h30 HE | Element Materials Technology
LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief...
22nd Century Group logo.jpg
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
11 avr. 2022 09h25 HE | 22nd Century Group, Inc
Further Enhances 22nd Century Group’s Deep Expertise in Plant-Based Biotechnology BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural...